Figure 4.

Protective actions of pinocembrin against cardiomyocyte injury responses in vitro. (a) Effect of pinocembrin (30 μM, added during reperfusion) on rat cardiomyocyte cTnI release subsequent to H/R. (b) Effect of pinocembrin on rat cardiomyocyte LDH release subsequent to H/R. (c) Effect of pinocembrin on mouse cardiomyocyte cTnI release subsequent to H/R. (d) Effect of pinocembrin on mouse cardiomyocyte LDH release subsequent to H/R. n = 5 each. Data represent the mean ± SEM. ^∗P < 0.05 versus normoxia with the vehicle group. ^#P < 0.05 versus H/R with the vehicle group.